e-learning
resources
Milan 2017
Wednesday, 13.09.2017
What is new in COPD management and prognosis: findings from large studies?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Elevated systemic biomarkers and persistent anxiety and depression in smokers with and without COPD: An analysis of the SPIROMICS cohort
V. Kim (Philadelphia, United States of America)
Source:
International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Session:
What is new in COPD management and prognosis: findings from large studies?
Session type:
Poster Discussion
Number:
4967
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Kim (Philadelphia, United States of America). Elevated systemic biomarkers and persistent anxiety and depression in smokers with and without COPD: An analysis of the SPIROMICS cohort. 4967
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Definition and history of sarcoidosis
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
Related content which might interest you:
High prevalence of current smokers among COPD patients with anxiety and depression symptoms
Source: Eur Respir J 2001; 18: Suppl. 33, 193s
Year: 2001
Smoking status and levels of anxiety and depression in hospitalized patients.
Source: International Congress 2018 – Effect of tobacco use on health
Year: 2018
The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort
Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation
Year: 2013
The correlation between depression and anxiety and pulmonary function in COPD patients
Source: Annual Congress 2010 - Comorbidities and disease management in primary care
Year: 2010
Positive association between the plasma levels of 5-hydroxyindoleacetic acid and the severity of depression in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Prevalence of anxiety and depression in COPD: are females at higher risk?
Source: Eur Respir J 2005; 26: Suppl. 49, 514s
Year: 2005
The role of evaluation of anxiety and depression in hospitalized asthma patients
Source: Annual Congress 2004 - Asthma and perceived health status
Year: 2004
Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Effect of depression and anxiety on the risk of exacerbation and hospitalization in COPD
Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD
Year: 2008
Smoking, anxiety and depression in relation to chronic respiratory diseases: results of population survey ROSEPID
Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung
Year: 2009
Quantification of smokers and smoking status among COPD patients, hospitalized for an exacerbation
Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions?
Year: 2011
Proteomic analysis of plasma from COPD patients and smoking control subjects
Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology
Year: 2007
Determinants of anxiety and depression among Filipino patients with chronic obstructive pulmonary disease: A multi-center study
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Relationship between depression and exacerbations in COPD: a response
Source: Eur Respir J 2008; 32: 1126-1127
Year: 2008
Relationship between respiratory symptoms (and diagnosis), anxiety or depression and smoking cigarettes: a population-based study
Source: Eur Respir J 2002; 20: Suppl. 38, 178s
Year: 2002
The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations
Source: Eur Respir J 2013; 41: 815-823
Year: 2013
The effects of anxiety and depression on treatment adherence in COPD patients
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Impact of pulmonary rehabilitation on anxiety and depression in patients with COPD
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008
Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease?
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Prevalence of anxiety and depression in 196 patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept